Deciphering the late steps of rifamycin biosynthesis

Rifamycin-derived drugs, including rifampin, rifabutin, rifapentine, and rifaximin, have long been used as first-line therapies for the treatment of tuberculosis and other deadly infections. However, the late steps leading to the biosynthesis of the industrially important rifamycin SV and B remain l...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Feifei, Lei, Chao, Li, Fengwei, Zhang, Xingwang, Wang, Jin, Zhang, Wei, Fan, Zhen, Li, Weichao, Tang, Gong-Li, Xiao, Youli, Zhao, Guoping, Li, Shengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002545/
https://www.ncbi.nlm.nih.gov/pubmed/29904078
http://dx.doi.org/10.1038/s41467-018-04772-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002545/
https://www.ncbi.nlm.nih.gov/pubmed/29904078
http://dx.doi.org/10.1038/s41467-018-04772-x

Ejemplares similares